Filing Flows

Filing Flows › Bausch Health Companies (BHC) › Q4 2025

Bausch Health Companies (BHC) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 19, 2026

Bausch Health Companies (BHC) reported revenue of $2.8B for the fourth quarter 2025 (Q4 2025), +9% from a year earlier and +4% from the quarter before. Operating margin was 17.0%, net loss $103M (3.7% of revenue).

Revenue$2.8B
Year over year+9%
Quarter over quarter+4%
Operating margin17.0%
Net earnings−$103M

Bausch Health Companies, Q4 2025: revenue $2.8B (+9% year over year), operating margin 17.0%, net loss $103M, operating cash flow $495M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$2.8B+4%+9%
Operating profit$474M-23%—
Net earnings−$103M-158%—
Operating cash flow$495M+22%-18%
Free cash flow$403M+28%-19%

What changed

Revenue was $2.8B in Q4 2025, up 9% year over year and up 4% from the previous quarter. Product sales was the largest line at 99% of revenue.

Operating profit was $0.47B, a 17.0% margin (down 4.9 points year over year). Operating profit fell $0.08B even though revenue rose $0.24B versus a year earlier, so costs grew faster than sales. Total costs grew 16% against revenue growth of 9%. The fastest-growing cost line was Other operating costs (+26%). The quarter ended with a net loss of $0.10B, after a profit of $0.18B the previous quarter. Net interest and other expense of $0.42B was the main reason.

Operating cash flow was $0.49B (down 18% year over year). Non-cash charges added back $0.29B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items added $0.22B. Capital expenditures of $0.09B left free cash flow of $0.40B.

Questions

What was Bausch Health Companies' revenue in the fourth quarter 2025?

Bausch Health Companies (BHC) reported revenue of $2.8B for the fourth quarter 2025 (Q4 2025), +9% from a year earlier and +4% from the quarter before.

Was Bausch Health Companies profitable in the fourth quarter 2025?

Operating profit was $474M (17.0% of revenue) and net loss $103M.

Open the interactive Sankey →

Source: Bausch Health Companies 10-K on SEC EDGAR.